Malignant idiopathic anaphylaxis does exist in Brazil

Annals of Allergy, Asthma and Immunology

Volumn 88, Issue 6, 2002, Pages 645-

  Geller, Mario ^a   Geller, Priscila ^a  

^a Geller Allergy and Immunology Clinic   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; FEXOFENADINE; KETOTIFEN; METHYLPREDNISOLONE; PREDNISONE; RANITIDINE; SALBUTAMOL;

AGED; ANAPHYLAXIS; BRAZIL; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; DISEASE COURSE; HUMAN; HYPERTENSION; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REMISSION;

EID: 0036627692     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61900-X     Document Type: Letter

References (4)

1. Patterson R. Idiopathic anaphylaxis. The evolution of a disease. Clin Rev Allergy Immunol 1999;17:425-428.
2. Ditto AM, Harris KE, Krasnick J, et al. Idiopathic anaphylaxis: a series of 335 cases. Ann Allergy Asthma Immunol 1996;77:285-291.
3. Patterson R, Fitzsimons EJ, Choy AC, Harris KE. Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen. Ann Allergy Asthma Immunol 1997;79:138-144.
4. Grammer LC, Shaughnessy MA, Harris KE, Goolsby CL. Lymphocyte subsets and activation markers in patients with acute episodes of idiopathic anaphylaxis. Ann Allergy Asthma Immunol 2000;85:368-371.